advertisement
Opere CA 26
Showing records 1 to 25 | Display only abstracts from Opere CA in IGR 25-1124868 Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae
Bush L
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124383 Glutathione Modulates Hydrogen Sulfide Release and the Ocular Hypotensive Action of Diallyl Polysulfide Compounds
Mhatre S
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124868 Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae
Robinson J
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124383 Glutathione Modulates Hydrogen Sulfide Release and the Ocular Hypotensive Action of Diallyl Polysulfide Compounds
Anjali R
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124868 Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae
Okolie A
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124383 Glutathione Modulates Hydrogen Sulfide Release and the Ocular Hypotensive Action of Diallyl Polysulfide Compounds
Sahai P; Auden J
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124868 Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae
Muili F; Opere CA
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124383 Glutathione Modulates Hydrogen Sulfide Release and the Ocular Hypotensive Action of Diallyl Polysulfide Compounds
Singh S; Njie Mbye YF
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124868 Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae
Whiteman M
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124383 Glutathione Modulates Hydrogen Sulfide Release and the Ocular Hypotensive Action of Diallyl Polysulfide Compounds
Njie Mbye YF
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124868 Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae
Ohia SE
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124383 Glutathione Modulates Hydrogen Sulfide Release and the Ocular Hypotensive Action of Diallyl Polysulfide Compounds
Ohia SE; Opere CA
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
124868 Neuroprotective Actions of Hydrogen Sulfide-Releasing Compounds in Isolated Bovine Retinae
Njie Mbye YF; Njie Mbye YF
Pharmaceuticals (Basel, Switzerland) 2024; 17: (IGR: 25-1)
100537 Unmet needs in glaucoma therapy: The potential role of hydrogen sulfide and its delivery strategies
Mhatre S; Opere CA; Singh S
Journal of Controlled Release 2022; 347: 256-269 (IGR: 23-1)
75475 Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy
Ohia SE
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 61-69 (IGR: 19-2)
75576 Regulation of Excitatory Amino Acid Transmission in the Retina: Studies on Neuroprotection
Opere CA; Heruye S
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 107-118 (IGR: 19-2)
75475 Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy
Robinson J; Mitchell L
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 61-69 (IGR: 19-2)
75576 Regulation of Excitatory Amino Acid Transmission in the Retina: Studies on Neuroprotection
Njie-Mbye YF
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 107-118 (IGR: 19-2)
75475 Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy
Ngele KK
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 61-69 (IGR: 19-2)
75576 Regulation of Excitatory Amino Acid Transmission in the Retina: Studies on Neuroprotection
Ohia SE; Sharif NA
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 107-118 (IGR: 19-2)
75475 Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy
Heruye S; Opere CA; Njie-Mbye YF
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 61-69 (IGR: 19-2)
55581 Lipid peroxidation: pathophysiological and pharmacological implications in the eye
Njie-Mbye YF; Kulkarni-Chitnis M; Opere CA; Barrett A; Ohia SE
Frontiers in physiology 2013; 4: 366 (IGR: 15-4)
22334 Inhibitory action of hydrogen sulfide on muscarinic receptor-induced contraction of isolated porcine irides
Monjok EM; Kulkarni KH; Kouamou G; McKoy M; Opere CA; Bongmba ON; Njie YF; Ohia SE
Experimental Eye Research 2008; 87: 612-616 (IGR: 10-4)
12593 Ocular pharmacology of bicyclic hexahydroaporphines
Ohia SE; Zhan GL; Leday AM; Opere CA; Kulkarni KH; Harris LC; Roche VF
Methods and Findings in Experimental and Clinical Pharmacology 2005; 27: 87-93 (IGR: 7-3)
6863 Potentiation of sympathetic neurotransmission in bovine isolated irides by isoprostanes
Opere CA; Awe SO; Harris LC; Leday AM; Ohia SE
Free Radical Research 2001; 35: 257-264 (IGR: 4-1)
